Obigen Pharma Inc. (TPEX:7876)

Obigen Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	180.16	148.86	204.54	427.41
Short-Term Investments	473.7	608.7	739.3	-
Cash & Short-Term Investments	653.86	757.56	943.84	427.41
Cash Growth	52.98%	-19.74%	120.83%	-
Other Receivables	77.59	76.62	1.23	0.03
Receivables	77.59	76.62	1.23	0.03
Prepaid Expenses	16.57	3.68	-	-
Other Current Assets	-	-	71.48	63.73
Total Current Assets	748.01	837.87	1,017	491.17
Property, Plant & Equipment	239.31	274.37	312.79	303.34
Other Intangible Assets	647.79	668.82	707.2	748.43
Other Long-Term Assets	13.5	13.12	16.18	8.68
Total Assets	1,649	1,794	2,053	1,552
Accrued Expenses	9.8	17.28	7.11	3.55
Current Portion of Leases	14.94	14.8	13.77	6.73
Other Current Liabilities	5.74	5.29	3.17	6.78
Total Current Liabilities	30.48	37.37	24.05	17.06
Long-Term Leases	73.65	81.16	95.96	49.69
Other Long-Term Liabilities	0.55	0.55	0.56	0
Total Liabilities	104.69	119.08	120.57	66.75
Common Stock	1,060	1,060	1,060	760.03
Additional Paid-In Capital	1,492	1,488	1,470	770.43
Retained Earnings	-1,009	-872.71	-598.41	-353.11
Comprehensive Income & Other	0.24	-	0.24	307.53
Shareholders' Equity	1,544	1,675	1,932	1,485
Total Liabilities & Equity	1,649	1,794	2,053	1,552
Total Debt	88.59	95.96	109.73	56.42
Net Cash (Debt)	565.26	661.6	834.11	370.99
Net Cash Growth	52.36%	-20.68%	124.83%	-
Net Cash Per Share	5.33	6.24	8.14	4.88
Filing Date Shares Outstanding	106	106	106	76
Total Common Shares Outstanding	106	106	106	76
Working Capital	717.53	800.5	992.5	474.11
Book Value Per Share	14.56	15.80	18.23	19.54
Tangible Book Value	896.14	1,006	1,225	736.44
Tangible Book Value Per Share	8.45	9.49	11.56	9.69
Machinery	196.17	194.95	163.01	160.2
Construction In Progress	-	-	9.72	26.76
Leasehold Improvements	177.77	177.77	168.51	138.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.